Connected Sensors segment to dominate the United States Connected Drug Delivery Devices Market
Increase in awareness
regarding the non-compliance of drug therapy is expected to drive the demand
for United States connected drug delivery devices market for the forecast
period.
According to TechSci Research report, “United
States Connected Drug Delivery Devices Market By Product Type (Connected
Sensors v/s Integrated Connected Devices) By Technology (Bluetooth, Near Field Communication,
Others) By Application (Asthma & COPD, Diabetes, Others) By End User
(Healthcare Providers v/s Homecare) By Region, Company Forecast &
Opportunities, 2026”, The United States connected drug delivery devices
market is expected to witness significant growth for the next five years.
Connected drug delivery devices aids to maintain proper administration of drugs
with ensuring no errors without the assistance of healthcare professionals. Connected
drug delivery devices are quick, patient-focused, user-friendly, and easily
accessible. These devices basically designed to support multifunctional tasks
along with support the patient superior supervision and counselling activity.
It consists of features such as reminders, adherence trackers, patient diaries
which collectively store all the patient information. Increasing occurrence of
chronic diseases such as diabetes, asthma and COPD is contributing to surge the
demand for connected drug delivery devices. Rise in demand for connected drug
delivery services by healthcare sector and home-care settings is expected to
boost the connected drug delivery devices product demand. Adoption of latest
technology is making connected drug delivery devices capable of drug
identification and delivery.
The COVID-19 outbreak across the world which has been
declared as pandemic by World Health Organization has affected several countries
adversely. Leading authorities in United States imposed lockdown restrictions
and released a set of precautionary measures to contain the spread of novel
coronavirus. Coronavirus affected patients started suffering from shortness of
breath along with coughing and sneezing. United States authorities increased
the capacity of hospitals as a greater number of patients were getting affected
daily and getting admitted into the hospital facilities. Self-administration of
drug delivery was promoted to provide proper treatment to patients which
boosted the connected drug delivery devices demand.
Browse XX Figures spread through XX Pages and an
in-depth TOC on "United States Connected Drug Delivery Devices Market”.
https://www.techsciresearch.com/report/united-states-connected-drug-delivery-devices-market/7593.html
United
States connected drug delivery devices market is segmented into product type, technology,
application, end user, regional distribution, and company. Based on end user,
market can be divided into healthcare providers and homecare. The healthcare
providers end user segment is expected to dominate the market for the forecast
period, 2022-2026. Increasing prevalence of chronic diseases along with cardiovascular
diseases, diabetes and chronic obstructive pulmonary diseases are some of the
critical diseases requiring proper treatment and follow up of prescribed
medicines. Use of connected drug delivery services is beneficial in disease
treatment as it maintains the health record of patients. It also monitors the
drug usage and ensure timely drug delivery; therefore, it is in high demand
from healthcare sector. Based on technology, market can be fragmented into Bluetooth,
near field communication, and others. The Bluetooth technology segment is
expected to account for major market share for the next five years as it
affordable and easily available than its other available counterparts. Bluetooth
technology is in high demand as it can assist in easy connection between
connected drug delivery device and smartphone. High usage and technological
advancements of the technology is expected to foster the demand for connected
drug delivery devices market.
Abbott
Laboratories, Inc., F. Hoffmann-La Roche Ltd. (USA), Teva USA, Merck & Co.,
West Pharmaceutical Services, Inc., Molex LLC (Phillips Medisize), Cohero
Health, Inc., Becton, Dickinson, and Company, Unilife Corporation are the
leading players operating in United States connected drug delivery devices
market. Manufacturers are increasingly focusing on research and development
process to fuel higher growth in the market. To meet evolving customer demand
with respect to better efficiency and durability, several connected drug
delivery devices manufacturers are coming up with their technologically
advanced offerings.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=7593
Customers can also
request for 10% free customization on this report.
“High-end
investments by the major players for research and development activities
coupled with inclusion of emerging technologies such as big data analytics,
artificial intelligence to upgrade the existing infrastructure of connected
drug delivery devices is expected to carte lucrative opportunities for the
market growth. Launch of novel products promoting maximum patient engagement
and connectivity along with rise in geriatric population in United States who
require the external assistance for drug consumption is expected to propel the
connected drug delivery devices market growth till 2026” said Mr.
Karan Chechi, Research Director with TechSci Research, a research based global
management consulting firm.
“United States Connected
Drug Delivery Devices Market By Product Type (Connected Sensors v/s Integrated
Connected Devices) By Technology (Bluetooth, Near Field Communication, Others)
By Application (Asthma & COPD, Diabetes, Others) By End User (Healthcare
Providers v/s Homecare) By Region, Company Forecast & Opportunities, 2026” has
evaluated the future growth potential of United States connected drug delivery
devices market and provided statistics & information on market size, shares,
structure and future market growth. The report intends to provide cutting-edge
market intelligence and help decision makers take sound investment decisions. Besides,
the report also identifies and analyzes the emerging trends along with
essential drivers, challenges, and opportunities in the of United States connected
drug delivery devices market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Web:
https://www.techsciresearch.com/